Delcath (DCTH) Director Elizabeth Czerepak Receives 22,500-Share Award

What Happened
Elizabeth Czerepak, a director of Delcath Systems, Inc. (DCTH), was granted a derivative award on 2026-05-13 for 22,500 shares. The filing shows an acquisition price of $0.00 for the derivative, indicating an option/award rather than an open-market purchase or sale. No immediate sale or cash proceeds were reported.

Key Details

• Transaction date: 2026-05-13 (reported on Form 4 filed 2026-05-14) — filing appears timely.
• Transaction type/code: A (award/grant); recorded as a derivative security (option/award) at $0.00.
• Shares involved: 22,500 underlying shares granted.
• Vesting/expiration (footnote): Vests at 1/12th per month beginning May 13, 2026 while Czerepak remains a director. Option expires the earlier of 10 years from grant or, for vested options, two years after last day of service.
• Shares owned after transaction: Not specified in the provided filing.
• No indication of a cashless exercise, sale, 10b5-1 plan, tax withholding, or gift in this filing.

Context: This was an equity grant (derivative award) to a director that vests over time; it is not an immediate purchase or sale and therefore does not reflect an immediate market commitment (e.g., neither a direct bullish buy nor a divestiture).